Sign in
4/A

Changes in Ownership

CNS Pharmaceuticals, Inc. Filed Acc 0001683168-23-007108

Options or other derivatives

  • Director acquired 15,975 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Cockroft Bettina M. · Director

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2023-09-14 Grant or award : show line 1 in the form Option to purchase common stock +6,500 8,599 D
2023-09-21 Grant or award : show line 2 in the form Option to purchase common stock +9,475 18,074 D
Loading xslF345X05/ownership.xml…